Federal Circuit backs PTAB in Johnson & Johnson patent appeal

The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board (PTAB) decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

J&J reaches $6m settlement over counterfeit surgical tools

9 February 2021 Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

Americas

Johnson & Johnson unit settles patent dispute over hypertension drug

28 January 2021 In a win for Johnson & Johnson, its Actelion unit has settled an infringement lawsuit after generic drug maker Laurus conceded that a patent for a pulmonary hypertension drug was valid.

More on this story

Americas

J&J reaches $6m settlement over counterfeit surgical tools

9 February 2021 Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

Americas

Johnson & Johnson unit settles patent dispute over hypertension drug

More on this story

Americas

J&J reaches $6m settlement over counterfeit surgical tools

9 February 2021 Johnson & Johnson has settled its case against Advanced Inventory Management, trading as eSutures, which it accused of distributing counterfeit and contaminated surgical tools.

Americas

Johnson & Johnson unit settles patent dispute over hypertension drug